跳至主要内容
临床试验/CTRI/2022/10/046150
CTRI/2022/10/046150尚未招募1/2 期

Clinical study of narayana taila nasya in vataj artava dusti

Department of Panchakarma Gurukul campus UAU Haridwar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年10月10日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Improvement of assessment on basis of parameters like-

研究概览

简要总结

Clinical study of Narayana Taila Nasya in Vataj Artava Dusti.

研究设计

研究类型
Interventional
盲法
Open Label

入排标准

年龄范围
15.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patients with signs and symptoms of vataj artava dusti such as vikrit artava varna, ruja and artava which is ruksh, tanu, fenil, alpa, vichinna and vilambit.
  • 2.Patients with polycystic ovaries.
  • 3.Patients having altered FSH/LH.
  • 4.Patients with oligomenorrhoea, dysmenorrhoea, hypomenorrhea and amenorrhoea.

排除标准

  • 1.Patients with haemoglobin less than 7 g/dl.
  • 2.Patients with psychiatric disorders, epilepsy, heart disease, etc 3.Patients with known cases who are immunocompromised like HIV etc; who have haematological disorders such as haemophilia, leukemia etc.
  • 4.Patients with uncontrolled DM, HTN, Hypothyroidism.

结局指标

主要结局

Improvement of assessment on basis of parameters like-

时间窗: 1 day and 45 day

tanu, vilambit, vichinna artava.

时间窗: 1 day and 45 day

Artava varna (Colour), Artava pramana, Ruja (Pain), Rajaha sarava avidhi (Duration of menses), tanu, vilambit, vichinna artava.

时间窗: 1 day and 45 day

Fenil artava

时间窗: 1 day and 45 day

次要结局

  • •CBC(•Hb%)

研究者

发起方
Department of Panchakarma Gurukul campus UAU Haridwar
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验